Primary Record
7-Ethylcamptothecin
- In stock
- 5,712 g
- Purity
- 98.6 %
- CAS
- 78287-27-1
Compound Identifiers & Properties
- CAS
- 78287-27-1
- PubChem CID
- 127584
- SMILES
- CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=CC=CC=C51
- Canonical SMILES
- CCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC
Names & Synonyms
- 7-Ethylcamptothecin
- 7-Ethyl camptothecin
- 78287-27-1
- 7-ethyl-camptothecin
- LPY7FE51IW
- Irinotecan USP Rc E
- AC1Q6APY
- RefChem:106074
- UNII-LPY7FE51IW
- Irinotecan EP Impurity F
- SN-22
- CHEMBL837
- 7-Ethyl-20(S)-camptothecin
- AC1L2S9N
- C22H20N2O4
- SN 22
- MFCD06657922
- Irinotecan Related Compound E
- DTXSID60228960
- MYQKIWCVEPUPIL-QFIPXVFZSA-N
- 7-Ethylcamptothecin (Standard)
- AC1Q2T75
- CHEMBL420146
- orb1303366
- SCHEMBL1005149
- SCHEMBL4979100
- 7-Ethyl-10-hydroxycamptothecin
- 7-Ethylcamptothecin, AldrichCPR
- SCHEMBL29363060
- HY-N2108R
- 7-Ethyl-10-hydroxy-camptothecin
- DTXCID10151451
- (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- CHEBI:191009
- KST-1A8421
- SN-38
- AMY24894
- HY-N2108
- ZINC5140293
- ANW-58095
- AR-1A6073
- BDBM50092821
- CE-007
- CID127584
- s5111
- AKOS015909654
- C22-H20-N2-O4
- AC-1267
- ACN-035264
- CCG-268367
- CS-O-30626
- EBC-615354
- KS-5291
- RL05034
- 7-Ethyl-10-hydroxy-20(S)-camptothecin
- AJ-53303
- AK-88554
- AN-15094
- BC200254
- S412
- SY013195
- 7-ETHYLCAMPTOTHECIN [USP IMPURITY]
- AB0018621
- AB3000018
- J448.356A
- TC-146840
- CS-0018629
- E0781
- ST24036156
- 7-Ethylcamptothecin, 98% - 100MG 100mg
- H11443
- IRINOTECAN RELATED COMPOUND E [USP-RS]
- M-1090
- (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4'
- 287E271
- A865061
- I14-3232
- (4s)-4,11-diethyl-4-hydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
- Irinotecan EP Impurity F; Camptothecin 7-Ethyl Impurity
- B2703-464837
- (S)-4,11-Diethyl-4-hydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (S)-
- (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- 82801-73-8
- (19S)-10,19-DIETHYL-19-HYDROXY-17-OXA-3,13-DIAZAPENTACYCLO[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]HENICOSA-1(21),2,4,6,8,10,15(20)-HEPTAENE-14,18-DIONE
- (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0?,??.0?,?.0??,??]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11.0^{4,9.0^{15,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (4S)-4,11-Diethyl-4-hydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
- (4S)-4alpha,11-Diethyl-4-hydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (R)-4-Ethyl-4-methyl-1,4a,12,13a-tetrahydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- (S)-4,11-Diethyl-4,9-dihydroxy-1,5,5a,12-tetrahydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- (S)-4,11-Diethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- (S)-4,11-DIETHYL-4-HYDROXY-1H-PYRANO(3,4:6,7)INDOLIZINO(1,2-B)QUIN OLINE-3,14(4H,12H)-DIONE
- (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (7-Ethyl-20(S)-camptothecin)
- 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4,11-DIETHYL-4-HYDROXY-, (4S)-
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (S)-; 7-Ethyl-20(S)-camptothecin; 7-Ethylcamptothecin; SN 22; Irinotecan Related Compound E; Irinotecan Hydrochloride Trihydrate Impurity F; Irinotecan Impurity F
- 4,11-diethyl-4,9-dihydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione
- 4,11-Diethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- 4,11-Diethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (SN-38)
- 4,11-Diethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- 680-163-8